ENTRY       D11700            Mixture   Drug
NAME        Elexacaftor, ivacaftor and tezacaftor;
            Trikafta (TN);
            Kaftrio (TN)
PRODUCT     TRIKAFTA (Vertex Pharmaceuticals Incorporated)
COMPONENT   Elexacaftor [DR:D11507], Ivacaftor [DR:D09916], Tezacaftor [DR:D11041]
CLASS       Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
REMARK      ATC code: R07AX32
            Product: D11700<US>
EFFICACY    Cystic fibrosis treatment
  DISEASE   Cystic fibrosis (CFTR F508del mutation) [DS:H00218]
TARGET      CFTR* [HSA_VAR:1080v1] [HSA:1080] [KO:K05031]
  PATHWAY   hsa02010(1080)  ABC transporters
            hsa04971(1080)  Gastric acid secretion
            hsa04972(1080)  Pancreatic secretion
            hsa04976(1080)  Bile secretion
METABOLISM  Enzyme: CYP3A [HSA:1576 1577 1551]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             R RESPIRATORY SYSTEM
              R07 OTHER RESPIRATORY SYSTEM PRODUCTS
               R07A OTHER RESPIRATORY SYSTEM PRODUCTS
                R07AX Other respiratory system products
                 R07AX32 Ivacaftor, tezacaftor and elexacaftor
                  D11700  Elexacaftor, ivacaftor and tezacaftor &lt;US&gt;
            USP drug classification [BR:br08302]
             Respiratory Tract/Pulmonary Agents
              Cystic Fibrosis Agents
               Conductance Regulator Potentiator
                Elexacaftor/ Tezacaftor/ Ivacaftor
                 D11700  Elexacaftor, ivacaftor and tezacaftor
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               D11700  Elexacaftor, ivacaftor and tezacaftor
            Target-based classification of drugs [BR:br08310]
             Transporters
              ABC transporters
               ABCC subfamily
                CFTR* [HSA_VAR:1080v1]
                 D11700  Elexacaftor, ivacaftor and tezacaftor &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D11700
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11700
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11700
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D11700
            Pharmacogenomic biomarkers [br08341.html]
             Germline mutations in genetic disorder treatments
              D11700
DBLINKS     PubChem: 405226566
///
